EN
登录

Viome获得2500万美元,聘请前亚马逊、Groupon、三星高管

Viome secures $25M, hires former Amazon, Groupon, Samsung executive

MobiHealthNews 等信源发布 2024-09-10 19:33

可切换为仅中文


Photo: AsiaVision/Getty Images

图片:亚视/盖蒂图片

Viome Life Sciences announced a $25 million internal Series D and the appointment of its new chief operating officer, Kal Raman.

Khosla Ventures, Marc Benioff, Bold Capital WRG Ventures and others participated in the round.

科斯拉风险投资公司(Khosla Ventures)、马克·贝尼奥夫(Marc Benioff)、博尔德资本WRG风险投资公司(Bold Capital WRG Ventures)和其他公司参加了本轮谈判。

Raman joins Viome as COO after previously holding the position of senior vice president of non-media business, marketing and retail technology at Amazon and chief digital officer at Samsung. He also formerly worked as chief operating officer at Groupon.

Raman之前曾担任亚马逊(Amazon)非媒体业务、营销和零售技术高级副总裁和三星(Samsung)首席数字官,之后加入Viome担任首席运营官。他还曾担任Groupon的首席运营官。

WHAT IT DOES

它的功能

The Washington-based company offers a total body intelligence test for users to obtain food recommendations and create custom-formulated supplements and probiotics, which Viome also develops and distributes.

这家总部位于华盛顿的公司为用户提供全身智力测试,以获得食物推荐,并创建定制配方的补充剂和益生菌,Viome还开发和分销这些补充剂和益生菌。

It also offers an oral health intelligence test with its VRx My·Biotics Oral Lozenges targeted at evaluating and improving one's oral bacteria.

它还提供口腔健康智力测试,其VRx My·Biotics口腔含片旨在评估和改善口腔细菌。

Viome will use the funds to bring Raman on as COO to spearhead the expansion of the company's offerings and launch its diagnostic division.

Viome将利用这笔资金聘请Raman担任首席运营官,率先扩大公司的产品范围,并成立其诊断部门。

'Armed with the world's largest database of human and microbial RNA (gene expression) and employing advanced AI technology, Viome stands at the forefront of early diagnosis of life-threatening and debilitating chronic diseases and cancers. By unraveling the complexities of microbial activity and its interactions with the human immune system, we are pioneering new ways to understand health at its core,' Naveen Jain, founder and CEO of Viome, told MobiHealthNews in an email. .

“Viome拥有世界上最大的人类和微生物RNA(基因表达)数据库,并采用先进的人工智能技术,在早期诊断威胁生命和衰弱的慢性疾病和癌症方面处于领先地位。Viome创始人兼首席执行官纳文·贾恩(NaveenJain)在一封电子邮件中告诉MobiHealthNews,通过揭示微生物活动的复杂性及其与人类免疫系统的相互作用,我们正在开创理解健康核心的新方法。。

'With over 30 predictive models already developed, our diagnostics division is poised to pioneer further innovations aimed at early detection of cancer, autoimmune disorders, and metabolic conditions. This recent infusion of funds propels us forward, accelerating our research and elevating the standards of preventative healthcare.'.

“随着超过30种预测模型的开发,我们的诊断部门准备开创旨在早期发现癌症,自身免疫性疾病和代谢状况的进一步创新。最近的资金注入推动了我们的前进,加速了我们的研究,提高了预防性医疗保健的标准。”。

MARKET SNAPSHOT

市场快照

Last year, Viome closed a $86.5 million oversubscribed Series C funding round, bringing its total raise to $175 million. The company also announced the launch of its Gut Intelligence Test in 200 CVS locations.

去年,Viome完成了8650万美元的超额认购C轮融资,使其总筹资额达到1.75亿美元。该公司还宣布在200个CVS地点启动肠道智能测试。

The funding came just two years after the company raised $54 million in a pre-Series C convertible round. It scored $56 million in Series B funding in 2019 and $15 million in August 2017.

就在两年前,该公司在C系列之前的一轮可转换融资中筹集了5400万美元。2019年,它获得了5600万美元的B系列资金,2017年8月获得了1500万美元。

In 2021, Viome received FDA breakthrough device designation for its mRNA analysis technology and AI platform, which detects early signs of oral and throat cancer through user saliva samples.

2021年,Viome因其mRNA分析技术和AI平台获得了FDA突破性设备指定,该平台通过用户唾液样本检测口腔癌和喉癌的早期迹象。

The same year, the company announced it was expanding its partnership with global pharma company GlaxoSmithKline to research and potentially develop interventions for some cancers and autoimmune diseases.

同年,该公司宣布将扩大与全球制药公司葛兰素史克(GlaxoSmithKline)的合作伙伴关系,以研究和开发针对某些癌症和自身免疫性疾病的干预措施。

The collaboration aimed to allow the companies to study the connection between the gut microbiome and some chronic diseases, like autoimmune disorders.

这项合作旨在让两家公司研究肠道微生物组与一些慢性疾病(如自身免疫性疾病)之间的联系。

The HIMSS Healthcare Cybersecurity Forum is scheduled to take place October 31-November 1 in Washington, D.C. Learn more and register.

HIMSS医疗保健网络安全论坛定于10月31日至11月1日在华盛顿特区举行。了解更多信息并注册。

Tags: Viome Life Sciences, Viome, digital health investment, at-home testing, home testing

More regional news

更多地区新闻

Advanced Rx, Sure Med Compliance partner to reduce opioid misuseBy Anthony VecchioneSeptember 10, 2024

Advanced Rx,Sure Med合规合作伙伴减少Anthony Vecchione2024年9月10日滥用阿片类药物

Exclusive: Hippocratic AI partners with academia to create curriculum for AI use in healthcareBy Jessica HagenSeptember 10, 2024

独家报道:希波克拉底人工智能与学术界合作,为人工智能在医疗保健中的应用创建课程Jessica HagenSeptember 10204

Apple unveils Watch Series 10 sleep apnea feature and AirPods Pro 2 hearing aid capabilitiesBy Jessica HagenSeptember 09, 2024

苹果推出手表系列10睡眠呼吸暂停功能和AirPods Pro 2助听器功能Jessica HagenSeptember 092024